Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aptargroup (ATR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,534,125
  • Shares Outstanding, K 62,931
  • Annual Sales, $ 2,765 M
  • Annual Income, $ 194,750 K
  • 60-Month Beta 0.80
  • Price/Sales 2.40
  • Price/Cash Flow 15.37
  • Price/Book 4.66

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.98
  • Number of Estimates 7
  • High Estimate 0.99
  • Low Estimate 0.97
  • Prior Year 0.99
  • Growth Rate Est. (year over year) -1.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
99.21 +5.34%
on 03/08/19
105.68 -1.11%
on 03/21/19
+2.95 (+2.90%)
since 02/25/19
3-Month
88.26 +18.41%
on 01/03/19
105.68 -1.11%
on 03/21/19
+14.81 (+16.51%)
since 12/24/18
52-Week
86.85 +20.33%
on 04/04/18
112.31 -6.95%
on 09/17/18
+17.74 (+20.44%)
since 03/23/18

Most Recent Stories

More News
Why Is AptarGroup (ATR) Up 2.4% Since Last Earnings Report?

AptarGroup (ATR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ATR : 104.51 (+0.65%)
Aptar Pharma's Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression

Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field...

ATR : 104.51 (+0.65%)
AptarGroup Grows on Business Transformation Amid Inflation

AptarGroup's (ATR) performance will be supported by business-transformation plan, product rollouts and acquisitions despite elevated costs and currency fluctuations.

AIN : 70.50 (+0.33%)
ALRM : 61.68 (+0.97%)
MLI : 30.95 (+0.78%)
ATR : 104.51 (+0.65%)
AptarGroup (ATR) Earnings & Revenues Top Estimates in Q4

AptarGroup (ATR) expects core sales to grow in each segment in first-quarter 2019.

ALRM : 61.68 (+0.97%)
AAXN : 52.89 (+1.61%)
EBF : 20.50 (+0.99%)
ATR : 104.51 (+0.65%)
AptarGroup (ATR) Surpasses Q4 Earnings and Revenue Estimates

AptarGroup (ATR) delivered earnings and revenue surprises of 9.52% and 3.15%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

ATR : 104.51 (+0.65%)
Aptar Reports Fourth Quarter and Annual Results

AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2018.

ATR : 104.51 (+0.65%)
AptarGroup (ATR) to Report Q4 Earnings: What's in Store?

AptarGroup (ATR) fourth-quarter results will benefit from successful product roll outs and focus on improving operations despite input cost inflation and customer plant shutdowns.

AMC : 15.30 (+1.59%)
ADMS : 7.30 (-4.70%)
ALSN : 45.28 (+1.57%)
ATR : 104.51 (+0.65%)
Aptar Joins the World Business Council for Sustainable Development

AptarGroup, Inc. (NYSE: ATR) announced today that it has joined nearly 200 forward-thinking companies as the newest member of the World Business Council for Sustainable Development (WBCSD)....

ATR : 104.51 (+0.65%)
BERY or ATR: Which Is the Better Value Stock Right Now?

BERY vs. ATR: Which Stock Is the Better Value Option?

BERY : 53.86 (+0.50%)
ATR : 104.51 (+0.65%)
Nasal Drug Delivery Systems Market 2018 Business Scope for forecast period 2027

self-medication are major factors expected to drive the growth of the market over the forecast period.

VRX.TO : 30.80 (-3.33%)
NVS : 93.31 (-0.12%)
PFE : 41.89 (+0.10%)
ATR : 104.51 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ATR with:

Business Summary

AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities...

See More

Key Turning Points

2nd Resistance Point 106.11
1st Resistance Point 105.31
Last Price 104.51
1st Support Level 103.37
2nd Support Level 102.22

See More

52-Week High 112.31
Last Price 104.51
Fibonacci 61.8% 102.58
Fibonacci 50% 99.58
Fibonacci 38.2% 96.58
52-Week Low 86.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar